NLM Gateway
A service of the U.S. National Institutes of Health
Your Entrance to
Resources from the
National Library of Medicine
    Home      Term Finder      Limits/Settings      Search Details      History      My Locker        About      Help      FAQ    
Skip Navigation Side Barintended for web crawlers only

Program for the Prevention of Vertical Transmission of HIV: The Peruvian Experience.

Garcia PJ, Velasquez C, Segura P, Sanchez J; International Conference on AIDS.

Int Conf AIDS. 2000 Jul 9-14; 13: abstract no. ThPeC5314.

P. J. Garcia, Peruvian National HIV and STD Control Program, Gregorio Escobedo 774 D, Jesus Maria, Lima 11, Peru, Peru, Tel.: +(511)460-6157, Fax: +(511)433-2761, E-mail: pattyg@u.washington.edu

Issue: The rising number of HIV infected women in Peru, along with the fact that over 90% of seropositive children are infected through vertical transmission, highlight the need for an intervention to reduce vertical transmission of HIV. Looseness=1 Description: In 1996, a program for the prevention of Vertical Transmission in Peru was started. It included: guidelines for counseling and screening for HIV in pregnant women, a campaign to promote screening, training for health professionals, an improved reporting system, and comprehensive care of HIV infected pregnant women including free AZT treatment during pregnancy and delivery. In 1997 the protocol implemented was similar to the one used in PACTG 076. In 1998 the program shifted to the modified Thai protocol (AZT 300 mg q 12h po starting at 35 weeks, 300 mg q 3h po during labor and delivery and AZT for 6 weeks formula feeding to the newborn). In July 1999 free ELISA screening to all pregnant women was added. The coverage of HIV screening for pregnant women seen at health centers nationwide increased from 2% in 1997 to 49% in 1999, although only about 50% of women deliver at health centers in Peru. The number of pregnant women diagnosed HIV positive increased from 168 in 1997 to 225 in the first 10 months of 1999. The coverage of treatment was 40% in 1997 and 42% in 1998. Forty three newborns received AZT and formula during 1998 and 72 during 1999. An evaluation has found that vertical transmission among women under the protocol is 7% compared to 33% for those not receiving treatment. Conclusions: A program for prevention of vertical transmission is feasible but require several important components: free screening, free treatment for mother and newborn, training and a public campaign. There is a need to extend the coverage to pregnant women who come only to deliver at the centers, or to those with poor access to health care. Studies using rapid HIV tests for screening and new treatment regimens will be undertaken.

Publication Types:
  • Meeting Abstracts
Keywords:
  • AIDS Vaccines
  • Acquired Immunodeficiency Syndrome
  • Child
  • Counseling
  • Disease Transmission, Vertical
  • Female
  • HIV Infections
  • HIV Seropositivity
  • Humans
  • Infant, Newborn
  • Mass Screening
  • Peru
  • Pregnancy
  • Zidovudine
  • methods
  • therapy
  • transmission
Other ID:
  • GWAIDS0004360
UI: 102241857

From Meeting Abstracts




Contact Us
U.S. National Library of Medicine |  National Institutes of Health |  Health & Human Services
Privacy |  Copyright |  Accessibility |  Freedom of Information Act |  USA.gov